Fundz

miDiagnostics raised €30M in a Series D funding round led by Thermo Fisher Scientific Inc. to accelerate the development of a sterility test for the BioPharma Industry.

PRIVATEDec 04, 2024

Amount Raised

€30 Million

Round Type

Series D

HeverleeManufacturingInformation TechnologyBiotechnologyHealth Care

Investors

AcychloVmf InvestPamicaThermo Fisher Scientific Inc.

Description

miDiagnostics, a Leuven-based qPCR technology company, raised €30M in Series D funding to develop tests for the BioPharma Industry. The funding round was led by Thermo Fisher Scientific Inc. with participation from other investors.

Who to call at miDiagnostics, and when

A new round usually means miDiagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day miDiagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at miDiagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at miDiagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

miDiagnostics

Location

Heverlee, Vlaanderen, Belgium

About

miDiagnostics is using silicon chip technology which will bring miniaturized, rapid, easy-to-use, lab-quality tests with built-in connectivity direct to the patient and clinician. Combining a nanofluidic processor on a chip and a compact reader, miDiagnostics can measure virtually any biomarker from an easily accessed sample. The Company is developing an extensive portfolio of tests for screening, diagnosis and monitoring of a wide range of health conditions, including infectious diseases. Spun out of the world-leading R&D and innovation hub in nanoelectronics and digital technologies, imec, and a research collaboration with Johns Hopkins University, the leading US research and medical centre, miDiagnostics’ goal is to enable fast, comprehensive and cost-effective health analysis, regardless of location. Based in Leuven, Belgium, miDiagnostics is a privately held company created in 2015.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment miDiagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for miDiagnostics's next move

See what Strategic adds

miDiagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.